Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
6m agoHovnanian Enterprises Reports Fiscal 2026 Second Quarter Results
6m agoLivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
6m agoKKR Sells CIRCOR Aerospace to Parker Hannifin for $2.55 Billion
7m agoCosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway
7m agoIntuitive Announces Innovations to Advance Quintuple Aim
Revvity, Inc. logo

Revvity, Inc.

About

94.80USD-1.07 -1.12%
Closed • Updated at 13:22 GMT+00:00
Market Cap$10.58B
P/E Ratio44.94
Volume1.42M
Beta1.76
RSI52.83
Gross Margin47.56%
Health TechnologyMedical Specialties

Revvity, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 5 2026
Revvity Announces Financial Results for the First Quarter of 2026
Apr 16 2026
Revvity Showcases Integrated Cancer Research Solutions at AACR Annual Meeting 2026
Apr 10 2026
Revvity to Hold Earnings Call on Tuesday, May 5, 2026
Apr 9 2026
Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows
Feb 5 2026
Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026

Community Chat

Ask AI

6ix6ixAIEvents